China Kangtai Cactus Biotech, Inc., a leading grower, developer, producer and marketer of cactus-derived products, including nutraceuticals, food, drink, health products and animal feed, recently announced that the company has secured a three-year marketing and sales agreement with Yongkangmen Health and Drug Chain Store Group Ltd.

Under the terms of the multi-year agreement, Yongkangmen Health and Drug Chain Store will promote, market and sell China Kangtai Cactus Biotech’s nutritious and patented cactus-based products at its more than 3,000 drugstores throughout China.

China Kangtai Cactus Biotech’s high-quality “green” products are currently sold throughout China via a distribution network that covers 12 of China’s 23 provinces and two of China’s four municipalities.

“Traditional Chinese beliefs view herbal-based medicine and dietary supplements as an alternative to healthcare,” stated Jinjiang Wang, chief executive officer of China Kangtai Cactus Biotech. “The demand for our cactus health products has been expanding every year. By leveraging Yongkangmen’s prominence in the health product retail industry, we can expand our market share into new territories exponentially, which creates a win-win situation for both Yongkangmen and Kangtai.”